SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-13-029065
Filing Date
2013-04-12
Accepted
2013-04-12 17:21:31
Documents
10
Period of Report
2013-04-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 5.06: Change in Shell Company Status
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a13-10024_18k.htm 8-K 111444
2 EX-2.1 a13-10024_1ex2d1.htm EX-2.1 873035
3 EX-10.1 a13-10024_1ex10d1.htm EX-10.1 104475
4 EX-10.2 a13-10024_1ex10d2.htm EX-10.2 109172
5 EX-10.3 a13-10024_1ex10d3.htm EX-10.3 86917
6 EX-10.4 a13-10024_1ex10d4.htm EX-10.4 16226
7 EX-10.5 a13-10024_1ex10d5.htm EX-10.5 15680
8 EX-99.1 a13-10024_1ex99d1.htm EX-99.1 24028
9 GRAPHIC g100241mmi001.jpg GRAPHIC 5714
10 GRAPHIC g100241mmi002.jpg GRAPHIC 4932
  Complete submission text file 0001104659-13-029065.txt   1357317
Mailing Address 111 BARCLAY BLVD LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31812 | Film No.: 13759415
SIC: 2836 Biological Products, (No Diagnostic Substances)